Literature DB >> 17252228

Primary mediastinal anaplastic alk-1-positive large-cell lymphoma of T/NK-cell type expressing CD20.

J Gonin1, H Kadiri, S Bensaci, A Le Tourneau, T J Molina, J Diebold, D J Abdellouche, J Audouin.   

Abstract

We describe an unusual case of ALK-1-positive primary mediastinal lymphoma with the morphology of an anaplastic large-cell lymphoma (ALCL) of T/NK cell type but expressing CD20. This tumour had T/NK morphology and immunophenotype, as demonstrated by its expression of CD30, EMA, ALK-1, CD7 and TiA-1 and the lack of expression of B-cell markers other than CD20. The significance of such a co-expression of a B cell-associated antigen in a case of ALCL of T/NK cell type is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17252228     DOI: 10.1007/s00428-007-0371-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

1.  A case of a diffuse large B-cell lymphoma of plasmablastic type associated with the t(2;5)(p23;q35) chromosome translocation.

Authors:  Patrick Adam; Tiemo Katzenberger; Harald Seeberger; Stefan Gattenlöhner; Juergen Wolf; Claus Steinlein; Michael Schmid; Hans-Konrad Müller-Hermelink; German Ott
Journal:  Am J Surg Pathol       Date:  2003-11       Impact factor: 6.394

2.  Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome.

Authors:  H Tilly; P Gaulard; E Lepage; C Dumontet; J Diebold; I Plantier; F Berger; M Symann; T Petrella; P Lederlin; J Brière
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

3.  Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall.

Authors:  X Yao; J Teruya-Feldstein; M Raffeld; L Sorbara; E S Jaffe
Journal:  Mod Pathol       Date:  2001-02       Impact factor: 7.842

Review 4.  CD20-Positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin's disease and review of the literature.

Authors:  R L Mohrmann; D A Arber
Journal:  Mod Pathol       Date:  2000-11       Impact factor: 7.842

5.  Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas.

Authors:  E Haralambieva; K A Pulford; L Lamant; S Pileri; G Roncador; K C Gatter; G Delsol; D Y Mason
Journal:  Br J Haematol       Date:  2000-06       Impact factor: 6.998

6.  CD20 (pan-B cell antigen) expression on bone marrow-derived T cells.

Authors:  K M Algino; R W Thomason; D E King; M M Montiel; F E Craig
Journal:  Am J Clin Pathol       Date:  1996-07       Impact factor: 2.493

7.  ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases.

Authors:  Randy D Gascoyne; Laurence Lamant; Jose I Martin-Subero; Valia S Lestou; Nancy Lee Harris; Hans-Konrad Müller-Hermelink; John F Seymour; Lynda J Campbell; Douglas E Horsman; Isabelle Auvigne; Estelle Espinos; Reiner Siebert; Georges Delsol
Journal:  Blood       Date:  2003-05-22       Impact factor: 22.113

8.  CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes.

Authors:  L E Hultin; M A Hausner; P M Hultin; J V Giorgi
Journal:  Cytometry       Date:  1993

9.  CD20-positive T-cell chronic lymphocytic leukaemia.

Authors:  A Takami; M Saito; S Nakao; H Asakura; T Nozue; Y Onoe; A Yachie; S Shiobara; T Matsuda
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

10.  CD20+ T-cell lymphoma. Neoplastic transformation of a normal T-cell subset.

Authors:  L Quintanilla-Martinez; F Preffer; D Rubin; J A Ferry; N L Harris
Journal:  Am J Clin Pathol       Date:  1994-10       Impact factor: 2.493

View more
  3 in total

Review 1.  CD20+ T cells: an emerging T cell subset in human pathology.

Authors:  Adrian Y S Lee
Journal:  Inflamm Res       Date:  2022-08-11       Impact factor: 6.986

2.  Increased expression of Trop2 correlates with poor survival in extranodal NK/T cell lymphoma, nasal type.

Authors:  Renjie Chen; Meiping Lu; Jun Wang; Dawei Zhang; Hong Lin; Huijun Zhu; Weiming Zhang; Lin Xiong; Jun Ma; Yuan Mao; Jin Zhu; Jiaren Xu
Journal:  Virchows Arch       Date:  2013-08-25       Impact factor: 4.064

Review 3.  CD20-positive NK/T-cell lymphoma with indolent clinical course: report of case and review of literature.

Authors:  Qing-ping Jiang; Shao-yan Liu; Yue-xin Yang; Xue-xian Tan; Juan Peng; Zhong-tang Xiong; Zhi Li
Journal:  Diagn Pathol       Date:  2012-10-02       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.